Literature DB >> 7803934

Antibacterial efficacy of ciprofloxacin in a case of endocarditis due to Cardiobacterium hominis.

K Vogt1, F Klefisch, H Hahn, H Schmutzler.   

Abstract

Endocarditis due to Cardiobacterium hominis is rare and may be treated with a variety of antibiotics. We isolated the bacteria from blood cultures of a patient with Cardiobacterium hominis endocarditis who could be successfully treated with ciprofloxacin. The bacterial features of Cardiobacterium hominis are presented, and susceptibility to ciprofloxacin is documented with bacterial killing curves employing peak and trough specimens of patient's serum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803934     DOI: 10.1016/s0934-8840(11)80640-7

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  4 in total

Review 1.  Cardiobacterium hominis endocarditis: Two cases and a review of the literature.

Authors:  A N Malani; D M Aronoff; S F Bradley; C A Kauffman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

2.  Cardiobacterium hominis endocarditis: A case report and review of the literature.

Authors:  Andrew Walkty
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

3.  Aortic homograft endocarditis caused by Cardiobacterium hominis and complicated by agranulocytosis due to ceftriaxone.

Authors:  Dominique Braun; Arthur Horovitz; Mihai Bertea; Rolf Jenni; Huldrych F Günthard
Journal:  BMJ Case Rep       Date:  2010-11-26

4.  Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis.

Authors:  Lisa M Avery; Catherine B Felberbaum; Muhammad Hasan
Journal:  IDCases       Date:  2018-02-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.